SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE

The medical condition or reason for a Sexual Health and HIV Episode.

Description

The medical condition or reason for a Sexual Health and HIV Episode.

The following codes are used within the data set:


	Diagnosis and/or treatment of infection or disease
A1	Primary syphilis
A2	Secondary syphilis
A3	Early latent syphilis
A4	Cardiovascular syphilis
A5	Neurosyphilis
A6	All other late and latent syphilis
A7A	Congenital syphilis
A10	Ocular syphilis
A11	Otosyphilis
B	Gonorrhoea
C1	Chancroid
C2	Lymphogranuloma venereum (LGV)
C3	Donovanosis
C4	Chlamydial infection
C4N	Non-specific genital infection (NSGI)
C5A	Pelvic inflammatory disease (PID) and epididymitis
C5B	Ophthalmia neonatorum
C6A	Trichomoniasis
C6B	Anaerobic/Bacterial vaginosis and anaerobic balanitis
C6C	Other vaginosis/vaginitis/balanitis
C7A	Anogenital candidosis
C8	Scabies
C9	Pediculosis pubis
C10A	Anogenital Herpes simplex: First episode
C10B	Anogenital Herpes simplex: Recurrent episode
C11A	Anogenital warts infection: First episode
C11D	Anogenital warts infection: Recurrent episode
C12	Molluscum contagiosum
C13	Viral hepatitis B (HbsAg positive): First diagnosis
C14	Viral hepatitis C: First diagnosis
C15	Viral hepatitis A: Acute infection
C16	Mycoplasma genitalium
D2A	Urinary Tract Infection
D2B	Other conditions requiring treatment at Level 3 Genitourinary Medicine Services
H	HIV positive - Previously Diagnosed
H1	New HIV diagnosis
H1A	New HIV diagnosis: Acute
H1B	New HIV diagnosis: Late infection (AIDS defined)
H2	Attendance for HIV-related care
P4A	Cervical cytology: minor abnormality
P4B	Cervical cytology: major abnormality
	Sexual Health Services Provided To record PATIENTS receiving Sexual Health Services or undergoing tests.
T1	Chlamydia test
T2	Chlamydia and gonorrhoea tests
T3	Chlamydia, gonorrhoea and syphilis tests
T4	Chlamydia, gonnorrhoea, syphilis and HIV antibody tests
T5	Herpes Simplex Virus (HSV) Test
T6	Hepatitis A/B/C Test
TS	Microscopy
TT	3 Site Testing (chlamydia and gonorrhoea)
T7	Syphilis and HIV Testing
T8	Self sampling (urinalysis/swabs) without Health Care worker (HCW) consultation
T9	STI testing not required/appropriate
T10	Rapid testing (STI and/or HIV)
T11	Chlamydia test declined
T12	Mycoplasma genitalium test
O20	Hepatitis A vaccination: 1st dose
O21	Hepatitis A vaccination: Subsequent dose
O22	Hepatitis A immune
O23	Partner notification related attendance: Hepatitis A contact
O31	PrEP eligibility criteria 1: MSM/transgender woman
O32	PrEP eligibility criteria 2: HIV positive partner
O33	PrEP eligibility criteria 3: Other high risk
O41	PrEP regimen: Starting or continuing daily Prep
O42	PrEP regimen: Starting or continuing event based Prep
O43	PrEP regimen: Continued through other source
O44	PrEP regimen: Offered and declined
O45	PrEP regimen: Stopped
O51	PrEP prescription: 30 tablets
O52	PrEP prescription: 60 tablets
O53	PrEP prescription: 90 tablets
O60	PrEP patient characteristic: Transgender
P1A	Human Immunodeficiency Virus (HIV) antibody test (no sexual health screen)
P1B	Human Immunodeficiency Virus (HIV) antibody test offered and refused
P1C	HIV test inappropriate
P2A	Hepatitis B vaccination: 1st dose
P2B	Hepatitis B vaccination: 2nd dose
P2C	Hepatitis B vaccination: 3rd dose
P2D	Hepatitis B vaccination: 4th dose
P2E	Hepatitis B vaccination: Booster
P2I	Hepatitis B immune
P3	CONTRACEPTION and family planning advice (excluding condom provision)
P4	Cervical cytology done
REF1	Referral from Chlamydia Screening Programme
REF2	Referral to a Level 3 Genitourinary Medicine Service
REF3	Referral from home testing/sampling service
SG1	Shigella flexneri (group B)
SG2	Shigella sonnei (group D)
SG3	Shigella other/unspecified
SRH	Sexual and Reproductive Health PATIENT
W1	HPV vaccination: 1st dose
W2	HPV vaccination: 2nd dose
W3	HPV vaccination: 3rd dose
W4	HPV vaccination: offered and declined
W5	HPV vaccination: previously received in full
PN	Partner notification initiated related attendance
PNC	Partner notification related attendance: Chlamydia contact
PNG	Partner notification related attendance: Gonorrhoea contact
PNH	Partner notification related attendance: HIV contact
PNN	Partner notification related attendance: Non-specific genital infection contact
PNP	Partner notification related attendance: PID/Epididymitis contact
PNS	Partner notification related attendance: Syphilis contact
PNT	Partner notification related attendance: Trichomoniasis contact
PR1	Pregnant 1-12 weeks
PR2	Pregnant 13-28 weeks
PR3	Pregnant 29-40 weeks
PEPS	Post exposure prophylaxis after sexual exposure (PEPSE)
D3	Other Sexual Health and HIV Episodes not requiring treatment
O11-O99	Research/New/Urgent reporting (Retired 01 October 2018)
40	Sexual Assault (Acute presentation)
41	Sexual Assault (Non - acute presentation)
	Findings
CSE1	Child sexual exploitation : concerns raised at internal assessment
CSE2	Child sexual exploitation : concerns raised with internal safeguarding professionals
CSE3	Child sexual exploitation : referred to external safeguarding professionals
DV	Concern of domestic violence (or abuse)
FGM	Female genital mutilation (of any type)
	Special PATIENT Groups To record additional information on certain PATIENT groups receiving Sexual Health Services or undergoing tests. Codes to be reported separately at each FIRST ATTENDANCE.
Z	Prisoner
SW	Sex Worker
	Suffixes to Codes To record additional information about the PATIENT's presentation or a Sexual Health Service given. This information may be collected through the use of suffixes which can be applied to the SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE. Where appropriate, multiple suffixes can be used on the same SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE. The suffixes and the codes with which they can be used are given below. These codes are appended to the SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE.
R	Rectal infection
O	Pharyngeal infection
X	Previously diagnosed elsewhere
M	Medication given
Q	Quadrivalent HPV vaccine
	Permissible Code Permutations Using Suffixes
	A - Syphilis
A1X	Primary syphilis - previously diagnosed elsewhere
A2X	Secondary syphilis - previously diagnosed elsewhere
A3X	Early latent syphilis - previously diagnosed elsewhere
A4X	Cardiovascular syphilis - previously diagnosed elsewhere
A5X	Neurosyphillis syphilis - previously diagnosed elsewhere
A6X	All other late and latent syphilis - previously diagnosed elsewhere
A7AX	Congenital syphilis - previously diagnosed elsewhere
	B - Gonorrhoea
BR	Gonorrhoea - rectal infection
BO	Gonorrhoea - pharayngeal infection
BX	Gonorrhoea - previously diagnosed elsewhere
BM	Gonorrhoea - medication given
BRX	Gonorrhoea - rectal infection, previously diagnosed elsewhere
BRM	Gonorrhoea - rectal infection, medication given
BOX	Gonorrhoea - pharayngeal infection, previously diagnosed elsewhere
BOM	Gonorrhoea - pharayngeal infection, medication given
	C4 - Chlamydia
C4R	Chlamydia - rectal infection
C4O	Chlamydia - pharayngeal infection
C4X	Chlamydia - previously diagnosed elsewhere
C4M	Chlamydia - medication given
C4RX	Chlamydia - rectal infection, previously diagnosed elsewhere
C4RM	Chlamydia - rectal infection, medication given
C4OX	Chlamydia - pharayngeal infection, previously diagnosed elsewhere
C4OM	Chlamydia - pharayngeal infection, medication given
	C2 - Lymphogranuloma (LGV)
C2R	Lymphogranuloma venereum (LGV) - Rectal infection
C2O	Lymphogranuloma venereum (LGV) - Pharayngeal infection
	C4N - NSGI
C4NR	Non-specific genital infection (NSGI) - rectal infection (proctitis)
	C6A - Trichomoniasis
C6AX	Trichomoniasis - previously diagnosed elsewhere
	H1 - New HIV diagnosis
H1X	New HIV diagnosis - previously diagnosed elsewhere
	H1A - New HIV diagnosis: acute
H1AX	New HIV diagnosis: acute - previously diagnosed elsewhere
	H1B - HIV diagnosis: late (AIDS defined)
H1BX	New HIV diagnosis: late (AIDS defined) - previously diagnosed elsewhere
	C10A - Anogenital Herpes simplex: first episode
C10AM	Anogenital Herpes simplex: first episode - medication given
	C10B - Anogenital Herpes simplex: recurrent episode
C10BM	Anogenital Herpes simplex: recurrent episode - medication given
	C11A - Anogenital warts infection: first episode
C11AM	Anogenital warts infection: first episode - medication given
	C11D - Anogenital warts infection: recurrent episode
C11DM	Anogenital warts infection: recurrent episode - medication given
	W1 - HPV Vaccination: 1st dose
W1Q	HPV Vaccination: 1st dose - quadrivalent vaccine
	W2 - HPV Vaccination: 2nd dose
W2Q	HPV Vaccination: 2nd dose - quadrivalent vaccine
	W3 - HPV Vaccination: 3rd dose
W3Q	HPV Vaccination: 3rd dose - quadrivalent vaccine

Also Known As

This attribute is also known by these names:

Context	Alias
Formerly	GENITOURINARY EPISODE TYPE
Plural	SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPES

Where Used

Type	Link	How used
Class	ACTIVITY PROPERTY	has an attribute SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE of type SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Attribute	PRISONER INDICATOR	references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Attribute	SEX WORKER INDICATOR	references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Data Element	SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE	is the data element of SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
Attribute	SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE	references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE

Data Elements